Wirth M. Tyrrell C. Delaere K. Sanchez-Chapado M. Ramon J. Wallace D.M.A. Hetherington J. Pina F. Heyns C.F. Navani S. Armstrong J.
(2007)
Trial 24, one of three ongoing trials in the Early Prostate Cancer programme, is evaluating the efficacy and tolerability of bicalutamide (Casodex) 150 mg following standard care (radiotherapy, radical prostatectomy or ...